Developing innovative breakthrough
drugs to improve the quality of human life
drugs to improve the quality of human life
![](/Upload/goods/20220425/5e619d283f6f9c74e7ae91cee1e8ffb7.jpg)
We are committed to the development
of innovative drugs for autoimmune diseases
of innovative drugs for autoimmune diseases
![](/Upload/goods/20220304/2b67118614f14fcc2bba8de70e94955b.jpg)
Next Theme
01 / 02
![](/public/static/images/index/img2.png)
![](/public/static/images/index/img1.jpg)
![](/public/static/images/index/img7.png)
Through independent research and development, license-in and business development, we are committed to the exploration of innovative drugs for autoimmune diseases and to fulfill unmet medical needs and to improve the quality of human life.
R&D and Product Pipeline
QY201, independently developed by E-nitiate with global patents, is undergoing phase I clinical trial for atopic dermatitis. Other pipelines, such as QY101, QY211, QY301, are also about to enter the clinical stage.
News